Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
So-Young to Report Third Quarter 2023 Financial Results on November 20, 2023 2023-11-10 18:00
FEBICO actively seeking business partners in United States, introduces "High- Spermidine" chlorella health supplements to satisfy U.S. market 2023-11-10 17:08
TCT 2023: The Efficacy and Safety of the SMART Trial Presented by World Renowned Expert 2023-11-10 16:46
GC Genome Enters License Agreement with MP Group 2023-11-10 13:00
MVR-T3011 IV, Global First Intravenous Oncolytic Product, Successfully Concludes Phase I Clinical Study in the U.S. with Outstanding Safety Results 2023-11-10 08:00
Beyond2020 Improves Access to Clean Water for 10,000 Rural Malaysians 2023-11-10 03:27
PharmAbcine Receives Safety Review Committee Approval to Advance to Dose Level 2 of Clinical Trial of PMC-403 with Neovascular Age-related Macular Degeneration following Dose Level 1 Safety Data 2023-11-09 21:00
WuXi AppTec Named 2023 Global Contract Research, Development and Manufacturing Organization Company of the Year by Frost & Sullivan 2023-11-09 08:00
Holmusk Appoints Eze Abosi as Chief Growth Officer 2023-11-09 08:00
Porton Advanced Announces a Strategic Partnership with BioMap, with AI Models Facilitating AAV Gene Therapy Development 2023-11-08 22:31
Complete Genomics' DNBSEQ-T20x2RS* Named "Next Generation Sequencing Solution of the Year" by 2023 BioTech Breakthrough Awards Program 2023-11-08 22:00
China Jo-Jo Drugstores Announces Celebration of its 20th Anniversary 2023-11-08 21:30
Nuvilab Earns Top Honors in Korea's AI Startup 100, Transforming Food Industry with AI Food Scanner 3.0 2023-11-08 14:53
WuXi Biologics Receives AAA MSCI ESG Rating 2023-11-08 08:30
Rootique DUO launches on Indiegogo, revolutionizing hair loss treatment with a 15s mess-free process 2023-11-08 00:00
MAJOR FITNESS opens pre-orders on its less space, more exercises foldable power rack, the Lightning F35 2023-11-07 22:00
Nuevocor presents pre-clinical data at ESGCT and AHA meetings 2023-11-07 22:00
Recruitment target achieved for Phase II SAR-Bombesin prostate cancer trial 2023-11-07 21:58
Kexing Biopharm Attended CPHI Worldwide 2023 2023-11-07 20:09
Akeso's Cadonilimab (PD-1/CTLA-4) Phase III Trial Meets Primary Endpoint at Interim Analysis Demonstrating Strong Overall Survival Benefit as First-line Treatment in All-comer Patients with Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (GC/GEJC) 2023-11-07 20:00
1 36 37 38 39 40 772